Boots Ireland has announced new lower prescription medicine prices, leading to significant savings for Irish customers. The prices of the majority of prescription medicines will now be dramatically reduced. The top-ten most expensive medicines will all be reduced in price, with an average saving of 25%. The new prices will come into effect from Friday 1 June 2012.
Those living with chronic conditions such as asthma or cardiovascular disease who are not eligible for the GMS Medical Card scheme will benefit the most. Children who suffer from asthma could have a monthly prescription bill of €71.57. Now with the new prices from Boots, this will drop to €55.05, representing an annual savings of €198.24. A child suffering from eczema could face a monthly bill of €37.40. However, with Boots , they would now save €51.48.
Speaking about the announcement, Mary Rose Burke, Director of Pharmacy, Boots Ireland said, “In recent years, many of our customers have come under renewed financial pressures. In response to this, Boots Ireland is the first pharmacy retailer in Ireland to announce a commitment to delivering a clear and transparent pricing structure that will also result in significant savings for Boots Ireland customers. Our new structure reflects the important role that Boots Ireland pharmacists play in the provision of professional care in the communities they serve in our 65 pharmacy outlets nationwide.
Boots Ireland aims to be the leading healthcare partner in the community and is striving to achieve this by providing accessible healthcare solutions underpinned by the best value and care to customers. Boots mission is to provide dynamic and innovative healthcare services and solutions that deliver active care to customers around the country helping them to feel good in their everyday life.”
The cut in prescription medicine costs at Boots will make medicines far more affordable for customers. This is in addition to a wide range of pharmacy-led healthcare services and products on offer in Boots Ireland stores nationwide, offering people a greater choice, accommodating their needs and budgets, while ultimately helping to ensure better patient outcomes.
